Article

Prophylactic MMC helps prevent haze, improve acuity

Off-label use of mitomycin-C appears to prevent haze and improve visual acuity in patients with complicated LASIK flaps when used in conjunction with PTK or PRK.

Key Points

"We feel that this is a safe technique when used for the prevention of corneal haze when surface treatment is performed over complicated flaps," said Dr. Epstein. This technique avoids the need to make a new flap and removes pathology, he said.

"We like to use this technique routinely for treating LASIK patients whose surgery was a long time ago and who come in for late enhancements," Dr. Epstein said. "It's not necessarily used on every PRK patient. We believe it should only be used in 'high-risk' situations."

He said that he and his colleagues have been ardent supporters of MMC in refractive surgery since his partner, Parag A. Majmudar, MD, first-authored their original study on this subject (Ophthalmology. 2000;107:89-94). They initially used topical MMC to treat patients with haze and subepithelial fibrosis after RK, PRK, and LASIK, Dr. Epstein said; an ongoing investigation involves the prophylactic use of MMC for complicated LASIK flaps.

"Our belief was that, in treating patients who are at high risk with prophylactic adjunctive MMC, we would prevent the haze that was likely to occur following such surface treatments over flaps," Dr. Epstein said.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times)  ASCRS 2025: Joaquin De Rojas, MD, leverages machine learning model to predict arcuate outcomes
(Image credit: Ophthalmology Times) ASCRS 2025: AnnMarie Hipsley, DPT, PhD, presents VESA for biomechanical simulation of presbyopia progression
Shehzad Batliwala, DO, aka Dr. Shehz, discussed humanitarian ophthalmology and performing refractive surgery in low-resource, high-risk areas at the ASCRS Foundation Symposium.
(Image credit: Ophthalmology Times) ASCRS 2025: Advancing vitreous care with Inder Paul Singh, MD
(Image credit: Ophthalmology Times) The Residency Report: Study provides new insights into USH2A target end points
Lisa Nijm, MD, says preoperative osmolarity testing can manage patient expectations and improve surgical results at the 2025 ASCRS annual meeting
At the 2025 ASCRS Annual Meeting, Weijie Violet Lin, MD, ABO, shares highlights from a 5-year review of cross-linking complications
Maanasa Indaram, MD, is the medical director of the pediatric ophthalmology and adult strabismus division at University of California San Francisco, and spoke about corneal crosslinking (CXL) at the 2025 ASCRS annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Taylor Strange, DO, assesses early visual outcomes with femto-created arcuate incisions in premium IOL cases
(Image credit: Ophthalmology Times) ASCRS 2025: Neda Shamie, MD, shares her early clinical experience with the Unity VCS system
© 2025 MJH Life Sciences

All rights reserved.